GlassScriptPhysician profile
Joseph Berenholz
NPI 1730138173
$2,134.49
in general payments reported to CMS, 2019-2025
23 companies · $13.63 in 2025
The $13.63 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $250 · 2021: $418 · 2022: $384 · 2023: $216 · 2024: $196 · 2025: $13.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $439.17 | 2019-2023 | |
| Abbvie INC. | $306.10 | 2019-2022 | |
| Myovant Sciences INC. | $282.65 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $195.56 | 2023-2025 | Myfembree, Gemtesa |
| Vertical Pharmaceuticals, LLC | $171.79 | 2019 | |
| Avion Pharmaceuticals | $135.57 | 2019-2023 | Balcoltra |
| Therapeuticsmd, INC. | $127.25 | 2019-2022 | |
| Hologic Sales and Service, LLC | $125.62 | 2019-2023 | Acessa Provu System |
| Astellas Pharma US INC | $71.14 | 2023-2024 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $34.99 | 2022-2023 | Accrufer |
| Mayne Pharma Commercial LLC | $31.18 | 2024 | |
| Pfizer INC. | $28.48 | 2019-2023 | |
| Scynexis, INC. | $25.05 | 2022 | |
| Aspira Women'S Health INC | $19.67 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $19.16 | 2023 | Vivjoa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $18.55 | 2024 | Tymlos |
| Amag Pharmaceuticals, INC. | $18.32 | 2019 | |
| Novo Nordisk INC | $16.38 | 2022 | |
| Acessa Health INC. | $15.94 | 2019 | |
| Virtus Pharmaceuticals LLC | $15.48 | 2020 | |
| Allergan, INC. | $12.56 | 2019 | |
| Amgen INC. | $12.50 | 2019 | |
| Dysis Medical, INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Berenholz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.